WALTHAM, Mass., Nov. 18, 2021 /PRNewswire/ -- Thermo Fisher
Scientific Inc. (NYSE:TMO), the world leader in serving science,
today announced that it is giving notice of its intention to redeem
the following Senior Notes (the "Redemption"), representing an
aggregate total principal amount of approximately $2.2 billion, on December
3, 2021 (the "Redemption Date"):
- $1.1 billion aggregate principal
amount of 4.133% Senior Notes due 2025 (the "2025 Notes"); and
- $1.1 billion aggregate principal
amount of 4.497% Senior Notes due 2030 (the "2030 Notes" and,
together with the 2025 Notes, the "Notes").
The Notes will be redeemed at a redemption price equal to the
greater of (1) 100% of the principal amount of the Notes to be
redeemed and (2) the sum of the present values of the remaining
scheduled payments of the Notes to be redeemed discounted to the
Redemption Date on a semi-annual basis at a comparable treasury
rate plus 50 basis points in the case of both the 2025 Notes and
the 2030 Notes, plus, in each case, accrued and unpaid interest on
the Notes to be redeemed to, but excluding, the Redemption Date.
Thermo Fisher intends to fund the
Redemption using cash on hand.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, including, but not limited to, statements about the
Redemption and Thermo Fisher's
intended use of cash on hand to fund the Redemption. These
statements involve a number of risks and uncertainties that could
cause actual results to differ materially from currently
anticipated results, including risks and uncertainties relating to
completion of the Redemption. While we may elect to update
forward-looking statements at some point in the future, we
specifically disclaim any obligation to do so, even if
circumstances change and, therefore, you should not rely on these
forward-looking statements as representing our views as of any date
subsequent to today.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in
serving science, with annual revenue of approximately $35 billion. Our Mission is to enable our
customers to make the world healthier, cleaner and safer. Whether
our customers are accelerating life sciences research, solving
complex analytical challenges, improving patient diagnostics and
therapies or increasing productivity in their laboratories, we are
here to support them. Our global team of more than 90,000
colleagues delivers an unrivaled combination of innovative
technologies, purchasing convenience and pharmaceutical services
through our industry-leading brands, including Thermo Scientific,
Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab
Services and Patheon. For more information, please visit
www.thermofisher.com.
Media Contact Information:
Ron O'Brien
Phone: 781-622-1242
E-mail: ron.obrien@thermofisher.com
Investor Contact Information:
Rafael Tejada
Phone: 781-622-1356
E-mail: rafael.tejada@thermofisher.com
View original
content:https://www.prnewswire.com/news-releases/thermo-fisher-scientific-announces-redemption-of-senior-notes-301427894.html
SOURCE Thermo Fisher Scientific